Efficacy of Acupuncture Treatment for Incidence of Poststroke Comorbidities: A Systematic Review and Meta-Analysis of Nationalized Cohort Studies.
Li-Kung WuChung-Shan HungYen-Lun KungZhong-Kui ChenShinn-Zong LinJaung-Geng LinTsung-Jung HoPublished in: Evidence-based complementary and alternative medicine : eCAM (2022)
Acupuncture has been applied as a complementary therapy in stroke survivors worldwide and approved to be beneficial to stroke recovery. However, there is little medical evidence regarding the association between acupuncture and the risk of poststroke comorbidities. We reviewed big data studies from the Taiwan National Health Insurance Research Database to investigate the risk of poststroke comorbidities after acupuncture treatment in a real-world situation. Ten English (PubMed, Embase, Medline, Cochrane, Alt HealthWatch, CINAHL, Health Source, PsycINFO, PsycARTICLES, and Psychology and Behavioral Sciences Collection) and two Chinese (AiritiLibray and Visualizing Health Data) electronic databases were searched from inception until December 2020 for nationalized cohort studies comparing the effects of acupuncture treatment with a nonacupuncture control group among stroke patients. Eight nationalized cohort studies were included. Six of eight studies showed a moderate overall risk of bias, while two studies showed a serious overall risk of bias. Included studies have investigated the effect of acupuncture in reducing the risk of seven medical conditions after stroke, including stroke recurrence, new-onset acute myocardial infarction (AMI), pneumonia, dementia, epilepsy, urinary tract infection (UTI), and depression. The meta-analysis showed clinically significant reductions in the risk of poststroke comorbidities in the acupuncture group compared to the nonacupuncture group (HR, 0.776; 95% CI, 0.719-0.838; p < 0.0001). In this systematic review and meta-analysis of nationalized cohort studies, acupuncture showed clinically relevant benefits in reducing the incidence of poststroke comorbidities, such as stroke recurrence, new-onset acute myocardial infarction (AMI), pneumonia, dementia, epilepsy, and UTI.
Keyphrases
- acute myocardial infarction
- systematic review
- big data
- urinary tract infection
- healthcare
- atrial fibrillation
- health insurance
- case control
- meta analyses
- public health
- upper limb
- percutaneous coronary intervention
- machine learning
- risk factors
- artificial intelligence
- mild cognitive impairment
- left ventricular
- randomized controlled trial
- emergency department
- heart failure
- young adults
- stem cells
- climate change
- acute coronary syndrome
- mesenchymal stem cells
- risk assessment
- cognitive impairment
- cerebral ischemia
- high resolution
- physical activity
- replacement therapy
- bone marrow
- mass spectrometry
- affordable care act
- subarachnoid hemorrhage
- sleep quality
- human health
- cell therapy